Algert Global’s Rocket Pharmaceuticals RCKT Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $837K | Buy |
341,760
+286,250
| +516% | +$701K | 0.02% | 843 |
|
2025
Q1 | $370K | Buy |
55,510
+15,450
| +39% | +$103K | 0.01% | 970 |
|
2024
Q4 | $504K | Buy |
+40,060
| New | +$504K | 0.01% | 905 |
|
2024
Q1 | – | Sell |
-24,710
| Closed | -$741K | – | 1236 |
|
2023
Q4 | $741K | Buy |
+24,710
| New | +$741K | 0.03% | 698 |
|
2023
Q1 | – | Sell |
-49,768
| Closed | -$974K | – | 1279 |
|
2022
Q4 | $974K | Sell |
49,768
-1,760
| -3% | -$34.4K | 0.05% | 579 |
|
2022
Q3 | $822K | Buy |
51,528
+10,758
| +26% | +$172K | 0.05% | 619 |
|
2022
Q2 | $561K | Buy |
40,770
+18,460
| +83% | +$254K | 0.04% | 718 |
|
2022
Q1 | $354K | Buy |
+22,310
| New | +$354K | 0.02% | 925 |
|
2021
Q1 | – | Sell |
-9,294
| Closed | -$510K | – | 511 |
|
2020
Q4 | $510K | Sell |
9,294
-13,127
| -59% | -$720K | 0.15% | 222 |
|
2020
Q3 | $513K | Hold |
22,421
| – | – | 0.16% | 189 |
|
2020
Q2 | $469K | Sell |
22,421
-5,409
| -19% | -$113K | 0.16% | 198 |
|
2020
Q1 | $388K | Buy |
+27,830
| New | +$388K | 0.16% | 205 |
|